Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Biologic Therapy/Immunobiology
•
Rheumatology
•
COVID-19
•
General Rheumatology
•
Tocilizumab
•
Biologics
Do you use tocilizumab for the treatment of severe COVID-19 in patients who are on other biologics for rheumatic diseases, such as rituximab?
Related Questions
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Do you regularly recommend an immunological workup for patients with suspected immunodeficiency or defer to immunology?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
How do you approach a patient with idiopathic anterior uveitis who has ongoing disease despite adalimumab every two weeks?
How do you approach a patient with Paget’s disease of bone with elevated alkaline phosphatase and history of chronic kidney disease?
How would you approach management of a patient with ankylosing spondylitis who was doing well on tofacitinib, but experienced a STEMI while on therapy?
How do you approach the significance of +RNP III antibody in a patient with positive ANA but no other signs or symptoms of systemic sclerosis?
What options are available for patients who require high dose steroids while taking strong CYP4A4 inducers?
Would you add immunosuppression for recurrent calcium kidney stones in a patient with sarcoidosis?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
